These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4870563)

  • 1. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
    Shepard CC; Tolentino JG; McRae DH
    Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of leprosy--effect of the anti-leprotic agent on the growth of acid-fast bacilli in cutaneous and mucous tissue].
    Hirano E
    Iryo; 1972 Mar; 26(3):243-53. PubMed ID: 4554827
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of DADDS in lepromatous leprosy.
    Ganapati R; Naik SS; Shah MH; Shirsat LS; Gaitonde BB
    Lepr India; 1976 Jul; 48(3):238-43. PubMed ID: 799207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1968 Sep; 17(5):769-75. PubMed ID: 4877714
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with 4,4'-diacetyldiaminodiphenylsulfone (DADDS) of leprosy patients in the Karimui, New Guinea.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1971 May; 20(3):495-501. PubMed ID: 4932529
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriological status (point prevalence) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Almeida JO; Araujo Arantes MA
    Bull World Health Organ; 1975; 52(1):57-62. PubMed ID: 764995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
    Languillon J; Yawalkar SJ; McDougall AC
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
    [No Abstract]   [Full Text] [Related]  

  • 11. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 12. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1972 Jul; 21(4):440-5. PubMed ID: 4559065
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in leprosy.
    Pettit JH
    Australas J Dermatol; 1968 Dec; 9(4):285-93. PubMed ID: 4886556
    [No Abstract]   [Full Text] [Related]  

  • 14. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of leprosy.
    Shepard CC
    Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of spectrophotofluorometric procedures to some problems in Mycobacterium leprae infections in mice and man treated with dapsone (DDS), diacetyl-DDS (DADDS), and di-formyl-DDS (DFD).
    Ozawa T; Shepard CC; Karat AB
    Am J Trop Med Hyg; 1971 Mar; 20(2):274-81. PubMed ID: 4928595
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.